Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving luciferase
Reexamination Certificate
2005-11-15
2005-11-15
Gitomer, Ralph (Department: 1651)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving luciferase
C424S009100, C424S009200
Reexamination Certificate
active
06964856
ABSTRACT:
Methods for selecting a candidate drug for treating sepsis are disclosed. The methods involve labeling a sepsis-causing pathogen with a reporter and monitoring the progress of infection by detecting levels of the reporter in animals treated with test compounds or drugs. The comparisons may be made between experimental and control animals, as well as within a single animal or group of animals. Also disclosed is a method for predicting an expected time of death of an experimental animal in a model system of sepsis using data generated in the initial part of the experiment.
REFERENCES:
patent: 5650135 (1997-07-01), Contag et al.
patent: 6020121 (2000-02-01), Bao et al.
patent: 6217847 (2001-04-01), Contag et al.
patent: 6610503 (2003-08-01), Bellinger-Kawahara et al.
patent: 0 864 648 (1998-09-01), None
patent: WO 96/40979 (1996-12-01), None
patent: WO 97/11690 (1997-04-01), None
patent: WO 97/18841 (1997-05-01), None
patent: WO 97/40381 (1997-10-01), None
patent: WO 00/36106 (2000-06-01), None
patent: WO 01/18195 (2001-03-01), None
patent: WO 01/18225 (2001-03-01), None
Larrick J. Generation of Protective Human Monoclonal for the Treatment of Gram Negative Sepsis. Progress in Clinical & Biological Research, vol. 272, pp. 383-393, 1988.
Oka Y. Selective Downregulation of Neutrophils by a Phosphatidic Acid Generation Inhibitor in a Porcine Sepsis Model. J of Surgical Research 81(2)147-155, 1999.
Contag et al., “Photonic Detection of Bacterial Pathogens in Living Hosts,”Molecular Microbiology18(4):593-603 (1995).
Contag et al., “Bioluminescent Indicators in Living Mammals,”Nature Medicine4(2):245-247 (1998).
Francis et al., “Monitoring BioluminescentStaphylococcus aureusInfections in Living Mice Using a Novel luxABCDE Construct,”Infection and Immunity68(6):3594-3600 (2000).
Louie et al, “Predictive Value of Several Signs of infection as Surrogate Markers for Mortality in a Neutropenic Guinea Pig Model ofPseudomonas aeruginosaSepsis,”Laboratory Animal Science47(6):617-623 (1997).
Bellinger-Kawahara Carole
Contag Pamela R.
Hubbard Alan
Gitomer Ralph
Robins & Pasternak LLP
Xenogen Corporation
LandOfFree
Animal models and methods for sepsis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Animal models and methods for sepsis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Animal models and methods for sepsis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3479247